Recent advancements in organ transplantation, such as gene-edited pig livers and 3D-printed tissue implants, are transforming healthcare by increasing organ viability and success rates. Companies like OrganOx have raised significant funding to enhance their liver preservation technology, allowing for longer transplant windows. Other players, like Paragonix, are innovating in organ transport, while eGenesis is advancing xenotransplantation using CRISPR to create compatible pig organs for human use. This new technology signals a shift in how transplant medicine is approached, tackling the critical shortage of available organs.
Gene-edited pig livers and 3D-printed tissue implants highlight the high-tech evolution of organ transplantation, presenting new business opportunities while enhancing success rates.
Collection
[
|
...
]